European Archives - Page 966 of 1138 - European Medical Journal

Allergen-Specific Immunotherapy

Allergen-specific immunotherapy remains the only causal treatment of allergic disease to date. Its efficacy in symptom reduction was demonstrated in…

Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

People with Type 2 diabetes mellitus (T2DM), compared with non-diabetic individuals, have increased cardiovascular risk. Part of this excess risk is…

Gene Delivery from Stents for Prevention of In-Stent Restenosis

The increasing sophistication of vascular stent design, especially devices that combine mechanical support with local drug delivery to the vascular wall…

Revolution of Drug-Eluting Coronary Stents: An Analysis of Market Leaders

Percutaneous coronary intervention with drug-eluting stents (DES) is a well-established and widely-accepted treatment approach in patients with coronary…

EMJ

First Project for the Winton Centre: Redesigning PREDICT

At the start of November 2016 the Winton Centre for Risk and Evidence Communication was opened within the Department of Pure Mathematics and Mathematical…

Sepsis-Induced Immune Paralysis Reversed by β-Glucan

SEPSIS is a life-threatening condition with inefficient treatment options available at present. With an incidence of approximately 2–30 per 10,000 people…

Association Found Between Vitamin D Levels and Breast Cancer Prognosis

VITAMIN D serum biomarker levels, particularly 25-hydroxyvitamin D, can be used to gauge vitamin deficiency or abundance among patients. In 2003 alone…

Enzyme Deficiency Provides New Treatment Target for Prader-Willi Syndrome

DEFICIENCY of the prohormone covertase (PC1) enzyme in the brain has been linked to the neuro-hormonal abnormalities found in patients with Prader-Willi…

EMJ

EMJ Weekly News Round-Up: 9th December

Keeping you up to date with the latest news, we summarise a selection of stories from us here at EMJ and from across the web!

EMJ

Use of NIV in COPD Patients

During this presentation Prof. Dr. Dreher shares his insights in the management of the COPD patient after an acute exacerbation.